Taro Pharmaceutical Industries Ltd. (TARO)
(Delayed Data from NYSE)
$107.44 USD
+0.88 (0.83%)
Updated May 3, 2019 04:02 PM ET
After-Market: $107.36 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
TARO 107.44 +0.88(0.83%)
Will TARO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TARO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TARO
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug
TARO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Procaps Group, S.A. (PROC) Q3 Earnings and Revenues Top Estimates
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis